More Research Needed to Prepare People With Mental Illness for Menopause
THURSDAY, May 15, 2025 -- Few studies examine how people living with a mental illness may be best prepared for the menopause transition, considering both menopause symptoms and psychiatric symptoms, according to a review published online May 6 in Menopause.
Tania Perich, Ph.D., and Kelly Kakakios, both from Western Sydney University, conducted a scoping review to assess the literature on psychoeducation programs that have been developed to address the menopause knowledge needs of people living with a mental illness.
The researchers identified five studies that utilized psychoeducation in the context of cognitive behavior therapy delivered as a treatment of either depression or menopause symptoms. These studies included women living with depression or bipolar disorder. For most conditions assessed (schizophrenia or schizoaffective disorder, personality disorder, posttraumatic stress disorder, anxiety disorders, obsessive-compulsive disorder, alcohol use, substance use, and eating disorders), no studies were identified that delivered any psychoeducation intervention to these populations.
"Overall, we have improved our understanding of the menopause transition and its potential effect on women's well-being and overall functioning," Claudio Soares, M.D., president of The Menopause Society, said in a statement. "However, this study is confirming what we know from other areas in medicine and public health -- that we need to do a better job in providing persons with severe mental illnesses with the information, resources, and care they need to manage their health throughout their lifespans -- including their midlife years."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
TUESDAY, Sept. 30, 2025 -- Elinzanetant, a dual neurokinin-targeted therapy, is effective for treating menopause-associated moderate-to-severe vasomotor symptoms (VMS), according...
Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions
FRIDAY, Sept. 26, 2025 -- U.S. hospitals that undergo private equity acquisition may reduce salaries and staffing after acquisition, especially in emergency departments (EDs) and...
Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum
FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.